We performed a retrospective review of medical charts regarding blood D-dimer levels 33 determined cross-sectionally by latex agglutination assay in 1952 samples from 1185 34 women to determine changes in D-dimer levels according to stage of pregnancy. Three 35 of 17 women in whom further investigations were performed were found to have 36 clinical venous thromboembolism (VTE). The median and 95 th percentile values of 37 D-dimer (g/mL) in the 1182 women without clinical VTE, 0.54 and 2.41 at gestational 38
INTRODUCTION 55
Pregnancy is a state characterized by hypercoagulability [1] and an increased risk of 56 venous thromboembolism (VTE) [2] , which is one of the leading causes of maternal 57 death in developed countries [3] . Although the risk of VTE is highest during the 58 postpartum period [4, 5] , many antenatal VTE events occur in the first trimester [6 -8] . 59 Therefore, VTE in pregnancy is a significant concern and recommendations for 60
prophylaxis have been reported [9] . 61
Measurement of the D-dimer level is useful for excluding VTE in non-pregnant patients 62 with suspected VTE [10 -12]. A D-dimer level of 0.2 -0.5 g/mL is usually used as the 63 cut-off value for non-pregnant women [10 -12] . However, as D-dimer level is elevated 64 physiologically during pregnancy [13 -19] , the cut-off value for non-pregnant 65 individuals is not useful because it has low specificity and positive predictive values. 66
Theoretically, D-dimer can be a useful tool, and three studies have suggested that a 67 higher cut-off value is useful for excluding pregnant women without VTE [17 -19] . 68
However, taking the consequent risks of VTE to the mother and fetus into consideration, 69
further studies comparing D-dimer levels between pregnant women with and without 70 VTE are required before definitive conclusions can be drawn regarding the usefulness 71 of D-dimer test in pregnant women. Accordingly, we conducted this retrospective study 72 trimester (GW 14 -27), early third trimester (GW 28 -35), and late third trimester 87 (GW 36 -42). Each subject usually underwent blood tests including determination of 88 D-dimer level several times. However, only the highest D-dimer value within each GW 89 category was used as the datum for the study subject. Finally, 1952 data on D-dimer 90 obtained from the entire pregnancy period of 1185 women were analyzed in this study. 91
These 1185 women accounted for 77.8% of 1523 women who gave birth at our hospital 92 during the study period. Data regarding patient age, parity, and clinical outcomes were 93 collected from the medial records. As our institution is a tertiary hospital, the rates of multifetal pregnancies, 129 pregnancy-induced hypertension, and cesarean delivery were higher than those in the 130 general Japanese population (Table 1) . Three women in the study population developed 131 clinical VTE during pregnancy. Of the 1182 women remaining after excluding the 3 132 women with VTE, 118, 372, 681, and 781 women without clinical VTE were examined 133 at GW 4 -13, 14 -27, 28 -35, and 36 -42, respectively ( Fig. 1 ). Of the 1182 women 134 without clinical VTE, only 17 and 6 exhibited D-dimer levels > 10 g/mL and > 14 135 g/mL, respectively, while all 3 women with clinical VTE exhibited a D-dimer level > 136 14 g/mL ( Fig. 2 ). Of the 17 women undergoing investigations for detection of clinical 137 VTE, 3 women with D-dimer levels of 14.6 (Case 1), 17.6 (Case 2), and 19.0 g/mL 138 (Case 3) were found to actually have clinical VTE. Mean values ± SD were 0.82 ± 0.79 139 g/mL at GW 4 -13, 1.78 ± 1.67 g/mL at GW 14 -27, 2.48 ± 2.36 g/mL at GW 28 -140 35, and 2.65 ± 1.94 g/mL at GW 36 -42 among the 1182 women without clinical 141 VTE. The median, 90 th , 95 th , and 99 th percentile values for D-dimer were determined for 142 the 1182 women within each GW category (Fig. 2) . The median and 99 th percentile 143 values (g/mL), 0.54 and 4.30 at GW 4 -13, increased gradually to 1.22 and 9.26 at 144 GW 14 -27, 1.81 and 10.95 at GW 28 -35, and to 2.13 and 10.32 at GW 36 -42, 145
respectively. The number of women with a D-dimer level ≥ 1.0 g/mL (threshold for 146 non-pregnant individuals), 21.2% (25/118) at GW 4 -13, increased to 59.4% (221/372) 147 at GW 14 -27, 85.2% (580/681) at GW 28 -35, and 92.3% (721/781) at GW 36 -42. ± 1.91 g/mL, P < 0.0001). However, mean D-dimer level for the 146 data from 93 152 hypertensive women with singleton pregnancies was not significantly higher than that 153 of their counterparts with singleton pregnancies (2.35 ± 2.03 vs. 2.31 ± 2.07 g/mL, P = 154 0.8244). Mean D-dimer level in the late 3 rd trimester was not affected by maternal 155 age; 2.80 ± 2.39 g/mL, 2.54 ± 1.67 g/mL, and 2.62 ± 1.75 g/mL for women with 156 product and heparin was initiated on the same day (hospital day 0). The D-dimer level 171 decreased gradually to around 1.0 g/mL on hospital day 11 (Fig. 3) . The patient left the 172 hospital on hospital day 15 after termination of her pregnancy on hospital day 7.
had not been treated with anti-coagulation therapy. She exhibited a high D-dimer level 176 of 17.6 g/mL (Fig. 3) , and a reduced AT level (33% of normal) on admission. 177 Treatment with AT product and heparin was initiated followed by a further increase in 178 D-dimer level to 23.6 g/mL 6 h after initiation of heparin. Echocardiography revealed 179 marked overload in the right ventricle and a diagnosis of pulmonary thromboembolism 180 was made. Her D-dimer level, which decreased to < 1.0 g/mL on hospital day 9 ( Fig.  181 3), increased gradually after GW 21 to 3.4 g/mL just before delivery while on heparin. a sensitivity of 100% with a specificity of 60% in a cohort including 8.7% women with 210 VTE. Chan et al. [19] later demonstrated that D-dimer level was significantly higher in 211 pregnant women with than in those without VTE in all of five more sensitive assay 212 methods (two rapid enzyme-linked immunosorbent assays and three latex agglutination 213 assays), and that use of higher cut-off values improved specificity up to 62% -79%, Kovac et al. [18] reported that D-dimer levels were higher in 9 of 10 pregnant patients 217 with VTE than the highest value according to each trimester of pregnancy. These results 218 together with those of the present study strongly suggested that pregnant patients with 219 VTE were likely to show an even higher D-dimer level than those without VTE. Similar 220 phenomenon was also suggested in women after cesarean sections [26] . 221
222
The numerical data of D-dimer differed between assay methods employed. As False-negative results can occur 7 -10 days after the onset of symptoms [28] . Therefore, 260 care is required when pregnant women exhibit a negative result but have had symptoms 261 suggestive of VTE, although data on the D-dimer in this study and those in previous 262 studies [17 -19] suggested that a higher cut-off value was clinically helpful for 263 excluding pregnant women without VTE. 264
265
We presented data on the D-dimer levels of 3 and 1182 pregnant women with and 266 without clinical VTE, respectively. The D-dimer levels in the three women who 267 developed VTE during pregnancy were well above the 99 th percentile values determined 268 for each trimester of pregnancy, suggesting that there may be a certain cut-off D-dimer 269 value that allows differentiation between pregnant women with and without VTE as 
